Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-120
Closed -$4K 1121
2024
Q3
$4K Hold
120
﹤0.01% 564
2024
Q2
$4K Hold
120
﹤0.01% 507
2024
Q1
$6K Sell
120
-180
-60% -$7.42K ﹤0.01% 418
2023
Q4
$11K Hold
300
﹤0.01% 267
2023
Q3
$10K Hold
300
﹤0.01% 270
2023
Q2
$10K Buy
300
+100
+50% +$3.59K ﹤0.01% 287
2023
Q1
$7K Hold
200
﹤0.01% 287
2022
Q4
$5K Hold
200
﹤0.01% 318
2022
Q3
$6K Buy
200
+25
+14% +$948 ﹤0.01% 310
2022
Q2
$10K Sell
175
-25
-13% -$1.38K ﹤0.01% 259
2022
Q1
$11K Buy
200
+80
+67% +$4.34K ﹤0.01% 223
2021
Q4
$7K Sell
120
-80
-40% -$4.16K ﹤0.01% 266
2021
Q3
$10K Buy
200
+80
+67% +$4.02K ﹤0.01% 230
2021
Q2
$6K Sell
120
-80
-40% -$3.84K ﹤0.01% 252
2021
Q1
$9K Buy
200
+80
+67% +$3.63K ﹤0.01% 228
2020
Q4
$6K Sell
120
-400
-77% -$18.4K ﹤0.01% 258
2020
Q3
$24K Buy
520
+400
+333% +$20K 0.01% 126
2020
Q2
$6K Hold
120
﹤0.01% 194
2020
Q1
$6K Buy
+120
New +$6.4K ﹤0.01% 191

Other funds holding GSK

Avion Wealth's GSK Position: Q4 2024 in Review

Avion Wealth sold out of GSK (GSK) in Q4 2024, closing a stake of 120 shares — an estimated $4K sold.

Avion Wealth first reported a position in GSK in Q1 2020 and held it in 19 quarters. The position peaked at $24K in Q3 2020. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Avion Wealth reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Avion Wealth sold 120 GSK shares in Q4 2024, an estimated $4K.
  • Avion Wealth first reported a position in GSK in Q1 2020 and held it in 19 quarters.
  • Avion Wealth's GSK position peaked at $24K in Q3 2020.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Avion Wealth's 13F filing for Q4 2024, filed 29 Jan 2025.